USPSTF: PrEP Use Is Recommended for all At-Risk Populations

More than 1 million Americans are currently living with HIV, and since the first cases were reported in 1981, more than 700,000 persons have died from AIDS. Although the infection is treatable, there is currently no cure—which is why the USPSTF says it is important to target the at-risk populations with preventive medication. 

Among its recommendations are:

 

In addition, the at-risk populations for HIV infection who should be considered for PrEP therapy include:

“The USPSTF concludes with high certainty that there is a substantial net benefit from the use of PrEP to reduce the risk of acquisition of HIV infection in persons at high risk of HIV infection,” the recommendation concluded.

Author
Tagbo Ekwonu, MD Medical Directror

You Might Also Enjoy...

How Can Transgender Southerners Get Better Healthcare?

More than 500,000 transgender people live in the South, according to the Williams Institute at the UCLA School of Law. National data show that nearly a quarter of trans people do not get any kind of healthcare because of a fear of discrimination.